| English Alias: |
((1S,4R)-7,7-Dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonic acid;(+)-CSA;(+)-camphor-10-sulfonicacid (beta);(1S)-(+)-10-Camphorsulfonic acid;2-oxobornane-10-sulphonic acid;(+)-camphor-10-sulphonic acid;L-(-)-Camphor-10-sulfonic acid monohydrate;(1S)-(+)-Camphor-10-sulphonic acid;d-2-oxobornane-10-sulfonic acid;D-10-CAMPHORSULFONIC ACID;D-(+)-CAMPHOR-10-SULFONIC ACID;D-CAMPHOR-10-SULFONIC ACID;D(-)-CAMPHORSULFONIC ACID;D-(+)-CAMPHOR SULFONIC ACID;D-CAMPHORSULFONIC ACIDl;D-(+)-camphour sulphonic acid;(+)-β-camphorsulfonic acid;(1S)-camphor-10-sulfonic acid;S(+)Camphor sulfonic acid;(1S)-(+)-Camphor-10-sulfonic acid;(+)-10-Camphorsulfonic Acid;((1S,4R)-7,7-Dimethyl-2-oxobicyclo-[2.2.1]heptan-1-yl)methanesulfonic acid;(+)-Camphor-10-sulfonic acid;D(+)-10-Camphorsulfonic acid;D-Camphorsulfonic acid;7,7-dimethyl-2-oxo-, (1S)-Bicyclo[2.2.1]heptane-1-methane sulfonic acid;(+)-Camphor-10-sulfonic acid (β);(+)-camphorsulfonicac;(1S)-(+)-10-Camphors;(S)-10-camphorsulphonic acid;camphersulfosaeure;CSA;D-(+)-10-Camphorsulfonic Acid;D-CAMPHORSULPHONIC ACID;D-REYCHLER'S ACID;1S-(+)-Camphor-10-sulfonic acid;D-Camphor sulfonic acid;[(1S,4R)-7,7-dimethyl-2-oxo-norbornan-1-yl]methanesulfonic acid;CAMPHORSULFONIC ACID, (+)-;DL-6-Oxobornane-10-sulphonic acid;UNII-9TLZ01S15L;2287183-06-4;EN300-384663;(RS)-10-CAMPHORSULFONIC ACID;AS-13390;(1S)-10-camphorsulfonic acid;NSC4167;CAMPHORSULFONIC ACID, (+/-)-;(R)-camphorsulfonic acid;(+/-)-Camphor-10-sulfonic acid;MFCD00074827;[(1S,4R)-7,7-dimethyl-2-oxobicyclo[2.2.1]hept-1-yl]methanesulfonic acid;(+/-)-Camphor-10-sulfonic acid, purum, >=98.0% (T);UNII-D8D049375Q;Voriconazole Impurity E;Camphor-10-sulfonic acid (beta), 98%;(+/-)-Camphor-10-sulfonic acid, 99%;D-Camphor sulfonic acid, United States Pharmacopeia (USP) Reference Standard;Camphersulfosaeure [German];NSC-4167;Bicyclo[2.2.1]heptane-1-methanesulfonic acid, 7,7-dimethyl-2-oxo-, (1S,4R)-;(1S)-(+)-CSA;Camphorsulfonic acid, d-;(1S,4R)-10-Camphorsulfonic acid;VORICONAZOLE IMPURITY E [EP IMPURITY];Camphor-10-sulfonic acid;CAMPHORSULFONIC ACID [WHO-DD];((1S,4R)-7,7-Dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonicacid;Voriconazole impurity E, European Pharmacopoeia (EP) Reference Standard;(+)-(S)-Camphor-10-sulfonic acid; (+)-2-Oxo-10-bornanesulfonic acid; (+)-Camphor-10-sulfonic acid; (+)-Camphor--sulfonic acid;10-Bornanesulfonic acid, 2-oxo-;DL-10-Camphorsulfonic acid;((1S,4R)-7,7-DIMETHYL-2-OXOBICYCLO(2.2.1)HEPT-1-YL)METHANESULFONIC ACID;3144-16-9;(1SR,4RS)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonic acid;(s)-camphorsulfonic acid;(7,7-Dimethyl-2-oxobicyclo(2.2.1)hept-1-yl)methanesulphonic acid;SCHEMBL60288;AI3-23953;MFCD00064157;[(1S,4R)-7,7-dimethyl-2-oxo-1-bicyclo[2.2.1]heptanyl]methanesulfonic acid;rel-((1S,4R)-7,7-Dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonic acid;D-CAMPHORSULFONIC ACID [MI];9TLZ01S15L;BCP21... |
